title: Autoimmune hemolytic anemia in a patient with primary ovarian non-Hodgkin's lymphoma.
abstract: The primary ovarian lymphoma is a rare disease with poor prognosis. The incidence of autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma is estimated at 3%. However, a substantial portion of the previously reported cases of ovarian lymphoma actually represented ovarian involvement by more diffuse lymphomatous process. If stringent criteria are used for case selection, true primary ovarian lymphoma usually carries a favorable prognosis. We present a primary malignant lymphoma of ovary accompanied by autoimmune hemolytic anemia in a 29-yr-old patient. After ablative surgery, the hemoglobin level and the reticulocyte count were normalized. One year following surgery and chemotherapy, the patient is alive and disease free.
authors.affiliation: Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea.
authors.forename: Chang Kil
authors.initials: CK
authors.lastname: Jung
authors.forename: Jong Seung
authors.initials: JS
authors.lastname: Park
authors.forename: Eun Ju
authors.initials: EJ
authors.lastname: Lee
authors.forename: Sung Hyun
authors.initials: SH
authors.lastname: Kim
authors.forename: Hyuk Chan
authors.initials: HC
authors.lastname: Kwon
authors.forename: Jae Seok
authors.initials: JS
authors.lastname: Kim
authors.forename: Mee Sook
authors.initials: MS
authors.lastname: Roh
authors.forename: Seoung Kook
authors.initials: SK
authors.lastname: Yoon
authors.forename: Kyeong-Hee
authors.initials: KH
authors.lastname: Kim
authors.forename: Jin-Yeong
authors.initials: JY
authors.lastname: Han
authors.forename: Hyo Jin
authors.initials: HJ
authors.lastname: Kim
mesh_terms: D000328:Adult; D000743:Anemia, Hemolytic / Q000276:immunology*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000276:immunology; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D010051:Ovarian Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D011239:Prednisolone / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D011239:Prednisolone